Comparison of the use of the cardioplegic material through the descending and ascending aorta in organ donation

Comparison of the use of the cardioplegic material through the descending and ascending aorta in the simultaneous removal of the heart and liver in organ donation: a randomized controlled clinical trial phase II

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220919055992N1

Enrollment

Registered

2022-11-03

Start date

2022-10-21

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Donors of organs and tissues. Donors of organs and tissues

Interventions

Intervention 1: Intervention group: This group contains organ donors who undergo an injection of a cardioplegic solution to descending aorta. Firstly sternotomy, complete isolation of aortic arch arte

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: eligible for organ donation have consent and aware of donation

Exclusion criteria

Exclusion criteria: liver cirrhosis heart failure prior heart surgery

Design outcomes

Primary

Measure	Time frame
The cardiac ejection fraction. Timepoint: right after surgery, 2 weeks, 1 month, 3 months, 6 months, and 1 year after the operation. Method of measurement: echocardiography.;The volume of the cardioplegic solution used in the surgery. Timepoint: at the operation. Method of measurement: fluid receiver.;The duration of the surgery. Timepoint: at the operation. Method of measurement: chornometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadhosein Akhlaghpasand

Shahid Beheshti University of Medical Sciences

akhlaghpasandm@yahoo.com+98 919 844 5400

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026